Moody's Corporation
MCO
$484.45
+0.21%
Moody's Corporation is a global provider of credit ratings on fixed-income securities and related risk-assessment services, operating through two segments: Moody's Investors Service (MIS), which rates corporates, structured finance, financial institutions, and public finance issuers, and Moody's Analytics (MA), which delivers decision solutions, research, data, and risk-modeling software. Alongside S&P Global, Moody's operates as one half of a dominant ratings duopoly, a position reinforced by regulatory recognition, issuer-pays economics, and decades of entrenched relationships that make its franchise one of the widest moats in financial services. The current investor debate centers on the durability of that moat in an AI era: bears point to the sharp de-rating of peer S&P Global on fears that generative AI could commoditize data and research workflows, while bulls argue Moody's Analytics is itself an AI beneficiary and that a recovering debt-issuance cycle is driving double-digit revenue growth. With MIS contributing roughly 41% and Analytics roughly 59% of segment revenue in the latest quarter, the narrative has shifted toward the resilience of recurring subscription revenue and margin expansion as issuance volumes normalize.…
MCO
Moody's Corporation
$484.45
Related headlines
Investment Opinion: Should I buy MCO Today?
Rating: Buy. The core thesis is that Moody's is a high-quality duopoly franchise with a wide moat, re-accelerating revenue growth (15.12% YoY), expanding margins, and a robust free cash flow of $3.398 billion, trading at a reasonable forward valuation of 25.9x earnings with a consensus buy rating and 14.2% upside to the average target of $552.14. Supporting evidence includes: (1) forward PE of 25.9x, which is near the low end of the historical range (22.5x to 54.3x), suggesting the market is pricing modest expectations; (2) revenue growth of 15.12% YoY, with sequential acceleration; (3) net margin of 31.86% and operating margin of 44.77%, both at the high end of the information-services sector; (4) free cash flow of $3.398 billion TTM, covering dividends and capex roughly 2.8x; and (5) analyst average target of $552.14, implying 14.2% upside, with the low target of $480 essentially at the current price, limiting downside. The biggest risks are: (1) AI disruption fears migrating from S&P Global to Moody's Analytics, which could compress the multiple; (2) a slowdown in debt issuance that would hit MIS revenue; and (3) the premium valuation leaving little room for error. The rating would upgrade to a stronger Buy if the stock breaks above $519 on volume and AI fears subside, and would downgrade to Hold if revenue growth decelerates below 10% or if the forward PE expands above 30x without commensurate growth. Relative to its history and peers, MCO is fairly valued to slightly undervalued on a forward basis, but premium on trailing metrics.
Sign up to view all
MCO 12-Month Price Forecast
The forward-looking view is bullish with medium confidence. Moody's is a high-quality franchise with a wide moat, and the current valuation on forward earnings (25.9x) is near the low end of its historical range, suggesting the market is pricing modest expectations. Revenue growth is re-accelerating, margins are expanding, and the analyst consensus is constructive with a $552 average target. However, AI disruption fears and a premium trailing multiple (37.2x) pose risks. I would upgrade to high confidence if the stock breaks above $519 on volume and AI fears subside, and downgrade to neutral if revenue growth decelerates below 10% or if the forward PE expands above 30x without commensurate growth.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Moody's Corporation's 12-month outlook, with a consensus price target around $552.14 and implied upside of +14.0% versus the current price.
Average Target
$552.14
0 analysts
Implied Upside
+14.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$480 - $600
Analyst target range
Coverage is deep and constructive: 21 analysts follow Moody's with a consensus recommendation of "buy" (mean rating 1.71 on a 1-to-5 scale where 1 is Strong Buy), and the average target price of $552.14 implies roughly +14.2% upside from the current $483.45. The consensus leans clearly bullish, and the institutional ratings flow is stable-to-positive — Wells Fargo, Baird, JP Morgan, and Barclays all reiterated Overweight/Outperform in July 2026, while Mizuho, Morgan Stanley, and BMO stayed Neutral/Equal Weight/Market Perform, indicating a split between bulls who see the issuance recovery and Analytics growth driving upside and holdouts who view the stock as fairly valued after its run. Notably, the current price sits just above the lowest analyst target of $480, meaning the market is pricing Moody's at the bear-case floor of published coverage. The target range of $480 to $600 is moderately wide — a 25% spread from low to high — signaling meaningful disagreement about the trajectory. The $600 high target likely assumes accelerating debt issuance, continued Analytics double-digit growth with AI-enabled product expansion, and multiple expansion back toward the upper half of the historical PE band; the $480 low target effectively prices in flat-to-modest growth, margin pressure from AI-related investment, or a softer issuance cycle, and its proximity to the current price suggests limited downside is embedded in the most cautious published view. The tight clustering of reiterated ratings (no upgrades or downgrades in the recent flow) points to high conviction in the franchise but low urgency to re-rate it, and with the average target 14% above spot and the low target essentially at spot, the risk/reward skews favorably for long-term holders.
Bulls vs Bears: MCO Investment Factors
The bull case currently has stronger evidence, anchored by 15.12% revenue growth, expanding margins (gross margin up to 76.29% from 67.65%), robust free cash flow of $3.398 billion, and a consensus buy rating with 14.2% upside to the average target. However, the bear case is not without merit: the stock has significantly underperformed the S&P 500 over the past year (-12.26 percentage points relative strength), trades at a premium valuation (37.2x trailing PE), and faces AI disruption fears that have already de-rated peer S&P Global. The single most important tension is whether Moody's Analytics can sustain its double-digit growth and margin expansion in the face of AI commoditization fears, or whether the premium multiple will compress as it did for S&P Global. Resolution of this debate—likely tied to upcoming earnings and AI-related product announcements—will determine whether the stock re-rates toward the $552 average target or de-rates toward the $480 low target.
Bullish
- Revenue re-accelerating at 15% YoY: Q2 2026 revenue of $2.185 billion grew 15.12% year-over-year, with sequential acceleration from $1.889 billion in Q4 2025 to $2.079 billion in Q1 2026 to $2.185 billion in Q2 2026. This trajectory supports the consensus forward revenue estimate of $10.51 billion, implying continued double-digit growth as the debt-issuance cycle recovers.
- Elite and expanding margins: Gross margin expanded to 76.29% in Q2 2026 from 67.65% a year earlier, while operating margin rose to 47.87% from 44.42%. Net margin reached 40.18% on $878 million of net income, demonstrating strong operating leverage as revenue outgrew a cost base that increased only from $1.055 billion to $1.139 billion.
- Analyst consensus buy with 14% upside: 21 analysts rate MCO a 'buy' with a mean rating of 1.71 and an average target price of $552.14, implying 14.2% upside from the current $483.45. The lowest target of $480 is essentially at the current price, suggesting limited downside embedded in the most cautious published view.
- Robust free cash flow and capital returns: TTM free cash flow is $3.398 billion, with Q2 2026 FCF of $874 million on operating cash flow of $779 million and capex of just $95 million. The company returned $1.547 billion in buybacks and $180 million in dividends in the quarter while still growing cash to $3.001 billion.
Bearish
- Significant underperformance versus S&P 500: MCO is up just 0.87% over the past year versus a 13.13% gain for SPY, a relative-strength gap of -12.26 percentage points, and it sits -3.11% year-to-date while the S&P is +11.45%. This persistent underperformance reflects investor skepticism about the growth outlook and AI disruption fears.
- Premium valuation leaves little room for error: At 37.2x trailing earnings, 11.85x sales, and 24.51x EV/EBITDA, MCO trades at a premium to its own historical forward multiple of 25.9x and to peer S&P Global, which recently traded at its cheapest valuation in years after a 25% decline. The PEG ratio of 1.75 suggests growth is priced fairly but not cheaply.
- AI disruption fears could migrate from peer: S&P Global's 25% stock decline was driven by fears that generative AI could commoditize data and research workflows. As the more expensive half of the ratings duopoly, Moody's is vulnerable if these concerns spread to its Analytics segment, which now represents 59% of segment revenue.
- Leveraged balance sheet in higher-rate environment: Debt-to-equity stands at 1.81, and while interest coverage of roughly 15.6x on Q2 operating income of $1.046 billion against $67 million of interest expense is comfortable, the debt load could become a headwind if rates remain elevated or if earnings decline.
MCO Technical Analysis
Moody's is in a choppy, range-bound consolidation rather than a clean trend: the stock is up just 0.87% over the past year versus a 13.13% gain for SPY, a relative-strength gap of -12.26 percentage points, and it sits -3.11% year-to-date while the S&P is +11.45%. At $483.45, the shares are trading at approximately 56% of the 52-week range (low $402.28, high $546.88), roughly 11.6% below the high and 20.2% above the low — a mid-range position that reflects indecision rather than momentum or deep value. The 180-day price series confirms this: a May trough near $428.90, a July peak at $519.02, a September slide to $441.36, and an October rebound, with a max drawdown of -23.61% along the way. Short-term momentum has turned constructive and is diverging positively from the weak 1-year record: the stock is +2.03% over one month and +2.53% over three months, and its 1-month relative strength of +3.05 points versus SPY is the only positive relative reading across the 1M/3M/6M/1Y/YTD windows. The October move from $441.36 on October 2 to $483.45 on October 23 (+9.5%) came on a modest 794,210-share session volume, so confirmation of the turn would require heavier participation; the 6-month gain of +6.01% is roughly in line with SPY's +6.45%, suggesting stabilization rather than leadership. Key levels are well defined: support sits at the $441–$447 shelf (the October 2 low of $441.36 and the 52-week floor at $402.28), while resistance lies at the July high of $519.02 and the 52-week high of $546.88. A breakout above $519 on volume would signal a resumption of the July uptrend and open a path toward the $546.88 high, whereas a breakdown below $441 would re-test the $402.28 low and validate the year-long downtrend. With a beta of 1.346, Moody's is roughly 35% more volatile than the market, so position sizing should account for amplified drawdowns — the -23.61% max drawdown is a realistic stress-case guide, and the 3.79 short ratio indicates a modest short base that could add fuel to an upside breakout.
Beta
1.35
1.35x market volatility
Max Drawdown
-23.6%
Largest decline past year
52-Week Range
$402-$547
Price range past year
Annual Return
-1.3%
Cumulative gain past year
| Period | MCO Return | S&P 500 |
|---|---|---|
| 1m | +3.4% | -0.8% |
| 3m | +0.1% | +3.3% |
| 6m | +5.3% | +7.6% |
| 1y | -1.3% | +13.0% |
| ytd | -2.9% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MCO Fundamental Analysis
Revenue is re-accelerating decisively: Q2 2026 revenue of $2.185 billion grew 15.12% year-over-year against $1.898 billion in Q2 2025, and the sequential progression from $1.889 billion in Q4 2025 to $2.079 billion in Q1 2026 to $2.185 billion in Q2 2026 shows a clear upward trajectory. The segment mix is tilting toward recurring revenue — Moody's Analytics contributed $1.284 billion versus $901 million from Moody's Investors Service in the latest period — meaning the subscription-heavy Analytics business now outweighs the more cyclical ratings franchise and dampens the earnings sensitivity to issuance volumes. Trailing four-quarter revenue of roughly $8.15 billion against a consensus forward estimate of $10.51 billion implies the Street expects continued double-digit growth, consistent with a recovering debt-issuance cycle and Analytics cross-sell; the growth trend supports the investment case that Moody's is compounding through the cycle rather than merely riding a ratings rebound. Profitability is elite and expanding: Q2 2026 net income of $878 million on a 40.18% net margin, gross margin of 76.29% (up from 67.65% in Q2 2025), and an operating margin of 47.87% versus 44.42% a year earlier, with EBITDA of $989 million at a 45.26% EBITDA ratio. The margin expansion is broad-based — gross margin climbed from 66.86% in Q4 2025 to 74.46% in Q1 2026 to 76.29% in Q2 2026 — and reflects operating leverage as revenue outgrows a cost base that rose only from $1.055 billion to $1.139 billion year-over-year. At a 31.86% trailing net margin and 44.77% operating margin, Moody's sits at the high end of what is typical for information-services and exchanges, consistent with its duopoly pricing power and asset-light model. The balance sheet is leveraged but comfortably serviced: debt-to-equity of 1.81, a current ratio of 1.74, and interest coverage of roughly 15.6x on Q2 operating income of $1.046 billion against $67 million of interest expense. Free cash flow is robust at $3.398 billion TTM, with Q2 2026 FCF of $874 million on operating cash flow of $779 million and capex of just $95 million, and the company returned capital aggressively — $1.547 billion of buybacks plus $180 million of dividends in the quarter — while still growing cash to $3.001 billion. ROE of 60.66% and ROA of 15.56% confirm exceptional capital efficiency, and with FCF covering dividends and capex roughly 2.8x, Moody's funds growth and shareholder returns internally without dependence on external financing; the main financial risk is the debt load in a higher-rate environment, but 15x+ interest coverage leaves ample cushion.
Quarterly Revenue
$2.2B
2026-06
Revenue YoY Growth
+15.1%
YoY Comparison
Gross Margin
76.3%
Latest Quarter
Free Cash Flow
$3.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MCO Overvalued?
Because Moody's is solidly profitable — Q2 2026 net income of $878 million and a positive trailing EPS — the PE ratio is the appropriate primary metric. The stock trades at 37.2x trailing earnings but only 25.9x forward earnings, a roughly 30% compression that signals the market expects meaningful EPS growth; consensus forward EPS of $26.97 versus the current run-rate implies the Street is underwriting continued double-digit earnings expansion, and the PEG ratio of 1.75 suggests that growth is being paid for at a reasonable, if not cheap, price. On the secondary metrics, the 11.85x P/S, 22.57x P/B, and 24.51x EV/EBITDA all sit at premium absolute levels, consistent with a high-margin, asset-light franchise where book value is small relative to earning power. Peer comparison is constrained by the absence of a supplied industry-average multiple, but the internal evidence is telling: Moody's 37.2x trailing PE compares with its own 22.5x reading in the June 2026 historical data and a 25.9x forward multiple, while peer S&P Global was described in recent coverage as trading at its cheapest valuation in years after a 25% decline — implying Moody's is currently the more expensive half of the ratings duopoly. That premium is defensible on quality grounds (60.66% ROE, 31.86% net margin, 76.29% gross margin) but leaves less room for error if issuance volumes soften or AI disruption fears migrate from S&P Global to Moody's. Historically, Moody's PE has ranged from roughly 22.5x (Q2 2026) to 54.3x (Q4 2024), with the 37.2x trailing multiple sitting in the middle-to-upper portion of that band; the forward multiple of 25.9x, however, is near the low end of the historical range, suggesting the market is pricing modest rather than euphoric expectations. The P/S ratio of 11.85x is far below the 36–48x readings in the historical ratios table, though that series appears computed on a different share/revenue basis and should be treated with caution; on the more comparable EV/EBITDA, the current 24.5x is well below the 80–104x historical enterprise-value multiples, again pointing to a valuation that has compressed rather than expanded. Net-net, the stock is not cheap on absolute multiples but is priced closer to the bottom than the top of its own historical band, which frames the debate as one of multiple re-rating potential versus the risk of further de-rating on AI or issuance-cycle concerns.
PE
37.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 23x~52x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are moderate but manageable. The debt-to-equity ratio of 1.81 and interest coverage of roughly 15.6x (Q2 operating income of $1.046 billion vs. $67 million interest expense) indicate the balance sheet is leveraged but comfortably serviced. However, the company's earnings remain sensitive to debt-issuance volumes, and while Analytics now contributes 59% of segment revenue, MIS still represents a significant cyclical exposure. Additionally, the premium valuation (37.2x trailing PE) depends on continued double-digit growth; any deceleration could trigger multiple compression. Margin expansion has been impressive, but sustaining gross margins above 76% may be challenging if AI-related investments increase or if the revenue mix shifts back toward lower-margin ratings. Market and competitive risks are elevated. The stock's beta of 1.346 means it is roughly 35% more volatile than the market, amplifying drawdowns during sector rotations. The recent de-rating of S&P Global by 25% on AI disruption fears highlights the risk that similar concerns could migrate to Moody's, especially given its premium valuation relative to S&P Global. Regulatory headwinds are ever-present for rating agencies, and any change in issuer-pays economics or increased competition from new entrants could pressure margins. Macro sensitivity is also a factor: a slowdown in debt issuance due to higher interest rates or economic uncertainty would directly hit MIS revenue. The worst-case scenario involves a combination of an AI-driven de-rating of Analytics, a cyclical downturn in issuance volumes, and multiple compression. In this scenario, the stock could retest its 52-week low of $402.28, representing a 16.8% decline from the current $483.45. If the bear case fully materializes and the stock falls to the analyst low target of $480, that would be a modest 0.7% decline, but a more severe outcome could see a drop to the 52-week low, a -16.8% move. Historically, the max drawdown over the past 180 days was -23.61%, which would imply a price near $369, below the 52-week low. Investors should be prepared for a potential 17-24% downside in an adverse scenario.
FAQ
The key risks are ranked as follows: (1) AI disruption risk—fears that generative AI could commoditize data and research workflows have already de-rated S&P Global by 25%, and Moody's Analytics represents 59% of segment revenue, making it vulnerable; (2) valuation compression risk—the premium trailing PE of 37.2x could compress if growth slows or if the market re-rates the sector; (3) cyclical issuance risk—MIS revenue is tied to debt issuance volumes, which could decline in a higher-for-longer rate environment; and (4) financial risk—debt-to-equity of 1.81 and a beta of 1.346 mean amplified drawdowns in market stress, with a max drawdown of -23.61% over the past 180 days. The most severe risk is AI disruption, as it could permanently alter the competitive landscape.
The 12-month forecast has three scenarios: bull case (30% probability) with a target range of $552-$600, driven by accelerating issuance, AI product wins, and multiple expansion; base case (50% probability) with a target range of $480-$552, assuming steady 10-15% revenue growth and stable margins; and bear case (20% probability) with a target range of $402-$480, assuming AI disruption fears spread and issuance slows. The most likely scenario is the base case, with the stock trading toward the analyst average target of $552.14, implying 14.2% upside. The key assumption is that revenue growth remains in the low-to-mid teens and that no major AI disruption materializes in the next 12 months.
MCO appears fairly valued to slightly undervalued on a forward basis. The forward PE of 25.9x is near the low end of its historical range (22.5x to 54.3x), suggesting the market is pricing modest expectations. However, on trailing metrics, the stock is premium: 37.2x trailing PE, 11.85x P/S, and 24.51x EV/EBITDA. Compared to peer S&P Global, which recently traded at its cheapest valuation in years after a 25% decline, MCO is the more expensive half of the duopoly. The PEG ratio of 1.75 indicates growth is priced reasonably. The market appears to expect continued double-digit earnings growth, but the premium trailing multiple leaves less room for error if growth disappoints.
From a risk/reward perspective, MCO offers a favorable skew: the analyst average target of $552.14 implies 14.2% upside, while the lowest target of $480 is essentially at the current price, suggesting limited downside based on published coverage. The forward PE of 25.9x is near the low end of its historical range, and the company's 15.12% revenue growth and expanding margins support the bull case. However, the biggest downside risk is AI disruption fears, which have already de-rated peer S&P Global by 25%, and a premium trailing PE of 37.2x leaves little room for error. For long-term investors with a 3-5 year horizon, MCO is a good buy at current levels, but short-term traders should be cautious given the stock's choppy technicals and beta of 1.346.
MCO is best suited for long-term investment. The company is a high-quality franchise with a wide moat, recurring revenue, and strong free cash flow, making it ideal for a 3-5 year holding period. The stock's beta of 1.346 and max drawdown of -23.61% suggest it can be volatile in the short term, and its recent underperformance versus the S&P 500 (-12.26 percentage points over one year) highlights the risk of short-term trading. The dividend yield of 0.77% is modest, so income is not a primary reason to own it. Earnings visibility is high given the recurring Analytics revenue, but the cyclical MIS segment adds some uncertainty. A minimum holding period of 2-3 years is recommended to ride out cyclical fluctuations and benefit from the long-term growth trajectory.

